Aster Capital Management »

Rapport Therapeutics shares owned by Aster Capital Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Aster Capital Management from 13F filings

Historical chart of Aster Capital Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Aster Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Aster Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.1k 300 30.34

More positions owned by Aster Capital Management

Broadcom (AVGO)
Wal-Mart Stores (WMT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
First Tr Exchange-traded Dj Internt Idx (FDN)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Comcast Corp Cl A (CMCSA)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (XHB)
Mettler-Toledo International (MTD)
Iqvia Holdings (IQV)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Waters Corporation (WAT)
Globalfoundries Ordinary Shares (GFS)

View all positions for Aster Capital Management

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics